Efficacy Study of Topical Application of Nifedipine Cream to Treat Vulvar Vestibulitis

NCT00496184 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2008-05-08

No results posted yet for this study

Summary

To evaluate the use of topical application of Nifedipine cream for the treatment of Provoked localized Vulvodynia (vestibulitis, vestibulodynia).

Conditions

  • Vulvar Diseases
  • Vulvar Pain
  • Vestibulitis
  • Vestibulodynia
  • Vulvodynia

Interventions

DRUG

Nifedipine cream topical application

Sponsors & Collaborators

  • Western Galilee Hospital-Nahariya

    lead OTHER_GOV

Principal Investigators

  • Jacob Bornstein, MD · Western Galilee Hospital, Nahariya, Israel

  • Doron Zarfati, MD · Western Galilee Hospital, Nahariya, Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2007-10-31
Completion
2008-05-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00496184 on ClinicalTrials.gov